Testing AI with AI: Ensuring Effective AI Implementation in Clinical Practice

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and nurses to rapidly diagnose heart issues in emergency departments.

"AI is becoming more common in healthcare, but it doesn’t always fit in smoothly with the vital work of our doctors and nurses," says Flinders University's Dr Maria Alejandra Pinero de Plaza, who led the research.

"We need to confirm these systems are trustworthy and work consistently for everyone, ensuring they are able to support medical teams rather than slowing them down."

Developed by Dr Pinero de Plaza and her team, PROLIFERATE_AI is a human-centred evaluation tool that uses artificial intelligence alongside researcher analysis to assess how well AI tools work in hospitals.

"In order to understand if the AI systems are viable, we look at how easy they are to use, how well doctors and nurses adopt them, and how they impact patient care," says Dr Pinero de Plaza, a research fellow in Flinders’ Caring Futures Institute.

"It's not just about making AI accurate; it’s about making sure it’s easy to understand, adaptable, and genuinely helpful for doctors and patients when it matters most."

Published in the International Journal of Medical Informatics, the study used PROLIFERATE_AI to assess the RAPIDx AI tool; designed to help emergency doctors quickly and accurately diagnose cardiac conditions by rapidly analysing clinical and biochemical data.

With chest pain one of the most common reasons for ED visits, the South Australian health system has been part of an NHMRC-funded trial being run across 12 hospitals in metropolitan and rural SA, which is currently analysing its 12-month patient outcomes.

Before and during the trial, the PROLIFERATE researchers evaluated the tool, with medical and nursing staff at the participating hospitals being provided the opportunity to share their insights on interacting with the RAPIDx AI tool.

The results showed that while experienced clinicians, such as ED consultants and registrars, demonstrated high comprehension and engagement with the RAPIDx AI tool, less experienced users, including residents and interns, faced usability challenges.

Registered nurses also reported strong emotional engagement with the tool, recognising its potential to enhance patient safety by reducing diagnostic uncertainty.

"What sets PROLIFERATE_AI apart is its ability to provide actionable insights," says Dr Pinero de Plaza.

"Rather than focusing solely on technical performance, we evaluate AI tools based on real-world usability and clinician trust, ensuring that these technologies are not just innovative but also practical and accessible.

"We want to set a new standard for AI implementation, fundamental care, and evaluation standards, starting with emergency medicine."

While the research demonstrated consultants and registrars benefited most from using RAPIDx AI, the study also highlighted the need for targeted training and workflow-aligned interfaces to improve adoption rates among new users.

It also demonstrated clinician desires in having further automated data integration into the user interface.

The authors say the findings highlight that AI in healthcare should always be developed with the end-users in mind.

"Our goal is to create AI solutions that empower doctors and nurses, not replace them," says Dr Pinero de Plaza.

"Technology alone cannot solve the complexities of emergency care. We need AI systems that work seamlessly with clinicians, support decision-making under pressure, and integrate smoothly into existing workflows.

"We are committed to enhancing our AI tools to ensure they are instinctively user-friendly and to develop customised training programs that meet the diverse needs of healthcare professionals and others."

Last month, the team received a CSIRO award from the On PRIME innovation program ($5000), which will aid in the continuous refinement of the predictive modelling and implementation science tool.

Pinero de Plaza MA, Lambrakis K, Marmolejo-Ramos F, Beleigoli A, Archibald M, Yadav L, McMillan P, Clark R, Lawless M, Morton E, Hendriks J, Kitson A, Visvanathan R, Chew DP, Barrera Causil CJ.
Human-centred AI for emergency cardiac care: Evaluating RAPIDx AI with PROLIFERATE_AI.
Int J Med Inform. 2025 Jan 28;196:105810. doi: 10.1016/j.ijmedinf.2025.105810

Most Popular Now

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI-Supported Breast Cancer Screening - N…

The new findings are published in The Lancet Digital Health. The initial results of the Mammography Screening with Artificial Intelligence (MASAI) study* - a randomised trial to evaluate whether AI...

AI Improves Personalized Cancer Treatmen…

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these...

The Future of Healthcare is Digital

8 - 10 April 2025, Berlin, Germany. The Berlin Exhibition Centre will be all about digital health from 8 to 10 April 2025. DMEA, Europe's leading event for digital healthcare, organised...

DMEA nova Award: Looking for the Best Id…

8 - 10 April 2025, Berlin, Germany. Innovative startups from the digital health sector can now apply for the DMEA nova Award 2025. We are looking for the best idea or...

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...